Amedeo Smart

Free Medical Literature Service

 

Amedeo

Nuclear Medicine
  Free Subscription

25.05.2026

1 AJNR Am J Neuroradiol
6 Ann Nucl Med
1 Circ Cardiovasc Imaging
13 Clin Nucl Med
4 J Nucl Cardiol
7 J Nucl Med
3 Nucl Med Commun
3 Nuklearmedizin
2 Phys Med Biol
1 Proc Natl Acad Sci U S A
2 Semin Nucl Med


    AJNR Am J Neuroradiol

  1. JASWAL S, Ghaderi Yazdi B, Khalafi M, Ozoria S, et al
    In Vivo [18F]MK6240 PET Reveals Atypical Patterns of Early Tau Deposition and Evidence for Primary Age-Related Tauopathy in Community-Residing Adults.
    AJNR Am J Neuroradiol. 2026 May 18:ajnr.A9420. doi: 10.3174/ajnr.A9420.
    >> Share


    Ann Nucl Med

  2. ERDOGAN M, Korkmaz H, Avci M, Ozdemir Z, et al
    Early clinical experience with (6)(8)Ga-Trivehexin PET/CT in parathyroid adenomas: a proof-of- concept imaging study.
    Ann Nucl Med. 2026 May 22. doi: 10.1007/s12149-026-02232.
    >> Share

  3. SOYDAS-TURAN B, Volkan-Salanci B, Aydin B, Kiratli P, et al
    18 F-FDG PET/CT Derived Volumetric Parameters Can Predict Outcome in Pediatric Ewing Sarcoma.
    Ann Nucl Med. 2026 May 21. doi: 10.1007/s12149-026-02229.
    >> Share

  4. LIN YC, Chang CC, Yeh TJ, Hsieh TY, et al
    Baseline FDG PET/CT SUVmax predicts POD24 and progression-free survival in newly diagnosed follicular lymphoma.
    Ann Nucl Med. 2026 May 20. doi: 10.1007/s12149-026-02230.
    >> Share

  5. USMANI S, Hashmi SF, Jain A, Al Saifi S, et al
    Integration of (6)(8)Ga-DOTA-TOC PET/CT into radiotherapy planning for intracranial meningiomas: A precision-imaging approach to tumor delineation.
    Ann Nucl Med. 2026 May 19. doi: 10.1007/s12149-026-02226.
    >> Share

  6. YAMAKUNI R, Seino S, Yamaki A, Shima A, et al
    Whole-brain histogram analysis and top 20% gray and white matter ratio of amyloid positron emission tomography: A comparison with the centiloid scale.
    Ann Nucl Med. 2026 May 18. doi: 10.1007/s12149-026-02218.
    >> Share

  7. CHIARAVALLOTI A, Egidi M, D'Agostini A, Filippi L, et al
    Semiquantitative SSTR PET metrics show molecular-morphologic discordance after 177Lu-DOTATATE in gastroenteropancreatic neuroendocrine neoplasms: an exploratory paired target-lesion analysis.
    Ann Nucl Med. 2026 May 18. doi: 10.1007/s12149-026-02231.
    >> Share


    Circ Cardiovasc Imaging

  8. GROSCHEL J, Heidecker B, Bhoyroo Y, Spethmann S, et al
    How to Image Myocarditis.
    Circ Cardiovasc Imaging. 2026;19:e018547.
    >> Share


    Clin Nucl Med

  9. OKSUZOGLU K, Perktas L, Onner H, Yilmaz F, et al
    Hepatic Perfusion-Related Pseudolesion Mimicking Metastasis on 68Ga-PSMA PET/CT.
    Clin Nucl Med. 2026 May 5. doi: 10.1097/RLU.0000000000006520.
    >> Share

  10. CHEN X, Zhang Y, Wu C, Fu Z, et al
    18F-FDG PET/CT in a Patient With Anal Angiosarcoma.
    Clin Nucl Med. 2026 May 11. doi: 10.1097/RLU.0000000000006429.
    >> Share

  11. KERROU K, Gligorov J
    Functional Estrogen Receptor Assessment: Insights From Discordant 18F-FES PET/CT and ER Immunohistochemistry.
    Clin Nucl Med. 2026 May 8. doi: 10.1097/RLU.0000000000006515.
    >> Share

  12. EL YAAGOUBI Y, Prunier-Aesch C, Wargnier O, Philippe L, et al
    Iliotibial Band Syndrome Detected by Bloodpool SPECT/CT Using New 3D-Ring CZT System.
    Clin Nucl Med. 2026 May 11. doi: 10.1097/RLU.0000000000006477.
    >> Share

  13. CHARBEL C, Woo S, Becker AS, Bruzzese A, et al
    Focal Small Bowel FDG Uptake in Cancer Patients Undergoing PET/CT: Prevalence and Etiology.
    Clin Nucl Med. 2026 May 5. doi: 10.1097/RLU.0000000000006480.
    >> Share

  14. DAI Y, Pan Z, Li D, Dong A, et al
    FDG PET/CT in a Case of Primary Bilateral Adrenal Dedifferentiated Liposarcoma.
    Clin Nucl Med. 2026 May 11. doi: 10.1097/RLU.0000000000006534.
    >> Share

  15. HE J, Zhang X, Dong A
    FDG PET/CT in a Case of Post-Hysterectomy Adnexal Torsion.
    Clin Nucl Med. 2026 May 11. doi: 10.1097/RLU.0000000000006522.
    >> Share

  16. TAGGAR M, Shamim SA, Jain R, Yadav SK, et al
    Agonist Trap Unmasked: 68Ga-DOTANOC Fibroid Mimicry Resolved by 68Ga-NODAGA-JR11 Antagonist PET.
    Clin Nucl Med. 2026 May 13. doi: 10.1097/RLU.0000000000006506.
    >> Share

  17. USMANI S, Elshafie O, Jain A, Al Rawahi A, et al
    68Ga-DOTATOC PET/CT in the Evaluation of Carney Triad Spectrum Tumors With an Associated Adrenal Adenoma.
    Clin Nucl Med. 2026 May 12. doi: 10.1097/RLU.0000000000006544.
    >> Share

  18. XIAO Z, Dong A, Zhang F, Zuo C, et al
    Bone Scintigraphy and FDG PET/CT in a Case of Pulmonary NUT Carcinoma With Only Initial Presentation of Bony Metastasis to the Distal Phalanx of the Little Finger Following Traumatic Injury.
    Clin Nucl Med. 2026 May 15. doi: 10.1097/RLU.0000000000006538.
    >> Share

  19. AL RIYAMI K, Jain A, Al Busaidi A, Ismaila A, et al
    Beyond FDG: Serial 68Ga-FAPI PET/CT for Staging and Treatment Response Assessment in Metastatic Pleomorphic Lobular Breast Cancer.
    Clin Nucl Med. 2026 May 15. doi: 10.1097/RLU.0000000000006540.
    >> Share

  20. CHENG J, Yuan H, Su M
    Pleural Metastasis as the Only Presentation of Recurrent Cervical Carcinoma on 18F-FDG PET/CT.
    Clin Nucl Med. 2026 May 15. doi: 10.1097/RLU.0000000000006545.
    >> Share

  21. ELAHIFARD H, Samadi MH, Saberifar M, Makhdoumi Y, et al
    Theranostic Application of FAPI in Advanced Laryngeal Squamous Cell Carcinoma: 99mTc-FAPI-46 SPECT/CT Guided 177Lu-FAPI-2286 Therapy.
    Clin Nucl Med. 2026 May 15. doi: 10.1097/RLU.0000000000006505.
    >> Share


    J Nucl Cardiol

  22. TERSALVI G, Tomasoni D, Coderre R, Kourelis TV, et al
    Cardiac amyloidosis: Disease overview and novel pathophysiologic insights.
    J Nucl Cardiol. 2026;59S:102723.
    >> Share

  23. MILLER RJ, Clerc OF, Cuddy SA, Auer B, et al
    Quantitative cardiac amyloid radionuclide imaging.
    J Nucl Cardiol. 2026;59S:102724.
    >> Share

  24. AL BADARIN F, Camilletti J, Benz DC, Better N, et al
    Cardiac amyloid radionuclide imaging: Global perspective and future priorities.
    J Nucl Cardiol. 2026;59S:102725.
    >> Share

  25. WALL JS, Martin EB
    An era of precision: Emerging, research, and adjunct radiotracers for nuclear imaging of cardiac amyloidosis.
    J Nucl Cardiol. 2026;59S:102726.
    >> Share


    J Nucl Med

  26. MULUGETA PG, O'Brien SR, Mankoff DA, Sartor O, et al
    A Call for High-Level Evidence Before Routine Implementation of Posttreatment SPECT.
    J Nucl Med. 2026 May 21:jnumed.125.271508. doi: 10.2967/jnumed.125.271508.
    >> Share

  27. WANG Y, Wood JL, Thurecht KJ, Yeoh SY, et al
    Assessing Value for Money in Theranostic Nuclear Medicine: A Systematic Review.
    J Nucl Med. 2026 May 21:jnumed.125.271469. doi: 10.2967/jnumed.125.271469.
    >> Share

  28. ARCAY OZTURK A, Liberale G, Deleu AL, Poenaru R, et al
    Preoperative Assessment of Peritoneal Carcinomatosis with [(68)Ga]Ga-FAPI-46 PET/CT: Agreement with Surgicopathologic PCI and Comparison with MRI and [(18)F]FDG PET/CT.
    J Nucl Med. 2026 May 21:jnumed.126.272183. doi: 10.2967/jnumed.126.272183.
    >> Share

  29. SOMMA C, Zimmermann R, Gericke G, Herrmann K, et al
    Targeted Radiopharmaceutical Therapy: Advances, Investment Dynamics, and Future Directions-Part 1.
    J Nucl Med. 2026 May 21:jnumed.125.270855. doi: 10.2967/jnumed.125.270855.
    >> Share

  30. LUCKERATH K, Minguez Gabina P, Eberlein U, Kurth J, et al
    Radiopharmaceutical Therapy Meets Radiobiology: Implications for Trial Design and DNA Repair Inhibitor Combinations.
    J Nucl Med. 2026 May 21:jnumed.125.271527. doi: 10.2967/jnumed.125.271527.
    >> Share

  31. SOMMA C, Zimmermann R, Gericke G, Herrmann K, et al
    Targeted Radiopharmaceutical Therapy: Advances, Investment Dynamics, and Future Directions-Part 2.
    J Nucl Med. 2026 May 21:jnumed.125.270945. doi: 10.2967/jnumed.125.270945.
    >> Share

  32. URIBE C, Iravani A, Savir-Baruch B, Jacene H, et al
    Reply: A Call for High-Level Evidence Before Routine Implementation of Posttreatment SPECT.
    J Nucl Med. 2026 May 21:jnumed.126.272083. doi: 10.2967/jnumed.126.272083.
    >> Share


    Nucl Med Commun

  33. HAROON A, Almuhaideb A, Adeleke S, Endozo R, et al
    From 18F-choline to prostate-specific membrane antigen PET: lessons from early multiparametric kinetic modelling in prostate cancer.
    Nucl Med Commun. 2026 May 19. doi: 10.1097/MNM.0000000000002166.
    >> Share

  34. WANG Y, Duan R
    Evaluating the role of quantitative dual lumbar vertebral radioactive counts ratio using 99m-technetium-labeled methylene diphosphonate single-photon emission computed tomography/computed tomography in the assessment of osteoporosis.
    Nucl Med Commun. 2026 May 22. doi: 10.1097/MNM.0000000000002182.
    >> Share

  35. JIA YN, Wu Q, Liu PH
    Evolutionary landscape and collaborative networks of global theranostic research in nuclear medicine: a visual bibliometric analysis.
    Nucl Med Commun. 2026 May 22. doi: 10.1097/MNM.0000000000002183.
    >> Share


    Nuklearmedizin

  36. BARTHEL H, Brendel M, Albert N, Boecker H, et al
    Updated Procedure Guideline of the German Society of Nuclear Medicine for Amyloid Brain PET Imaging 3.0.
    Nuklearmedizin. 2026;65:223-235.
    >> Share

  37. TATOGLU MT, Okten IN, Ibisoglu E, Soylemez Akkurt T, et al
    Baseline FDG PET/CT-Defined Axillary Burden Predicts Axillary Pathologic Complete Response After Neoadjuvant Therapy in Breast Cancer.
    Nuklearmedizin. 2026;65:207-216.
    >> Share

  38. SIEGMUND SC, Serfling SE, Higuchi T, Buck A, et al
    Emerging Theranostic Targets in Squamous Cell Carcinoma of the Head and Neck.
    Nuklearmedizin. 2026;65:217-222.
    >> Share


    Phys Med Biol

  39. SHIM HS, Cho MJ, He W, Lee MS, et al
    Influence of scintillation light confinement on depth-of-interaction measurement performance in a single-Ended readout PET detector.
    Phys Med Biol. 2026 May 15. doi: 10.1088/1361-6560.
    >> Share

  40. KUTOS JC, von Kietzell A, McGowan I, Bertoglio D, et al
    Image-derived input functions for [(18)F]LW223 and [(18)F]SynVesT-1 PET in the rodent determined using an autoencoder (IDIF-AE).
    Phys Med Biol. 2026 May 15. doi: 10.1088/1361-6560.
    >> Share


    Proc Natl Acad Sci U S A

  41. KALITA M, Kuo RC, Straniero V, Reyes ST, et al
    Illuminating proinflammatory myeloid cells with PET tracers targeting GPR84.
    Proc Natl Acad Sci U S A. 2026;123:e2536372123.
    >> Share


    Semin Nucl Med

  42. WOPPERER SB, Kronzer E, Ivare J, Taheri M, et al
    FDG PET for cardiac sarcoidosis: Protocol optimization, quantification, pitfalls, and multimodality imaging integration.
    Semin Nucl Med. 2026 May 21:S0001-2998(26)00093.
    >> Share

  43. HAMMOUD DA
    Imaging of immunocompromised patients: focus on fungal-specific PET tracers.
    Semin Nucl Med. 2026 May 18:S0001-2998(26)00095.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016